Deleterious consequences of Shiga toxin in the CNS
- 25 March 2026
- journal article
- review article
- Published by American Society for Microbiology in Microbiology and Molecular Biology Reviews
- Vol. 90 (1) , e0030125
Abstract
SUMMARY: The primary objective of this review is to provide an update on the most recent findings concerning the adverse effects of Shiga toxin-producing Escherichia coli (STEC) on the central nervous system (CNS), from both clinical and experimental perspectives. Considered the main predictor of death, STEC encephalopathy plays a critical role in hemolytic uremic syndrome (HUS), which affects between 11% and 64% of HUS patients and considerably increases the risk of morbidity and mortality. Of note, STEC encephalopathy in the absence of HUS has been observed in approximately 5% of cases. The ability of enterohemorrhagic E. coli to adapt to its microenvironment has been responsible for global outbreaks. Once in circulation, Shiga toxin rapidly induces endothelial damage via the Gb3 receptor. Brain inflammation in STEC encephalopathies has been consistently reported and experimentally confirmed. The entry of Shiga toxin into the brain leads to direct neuronal damage through its interaction with neuronal Gb3, as demonstrated in clinical case studies and experimental models. This review also discusses the adverse effects of STEC on the brain, which may arise from metabolic or circulatory disruptions, secondary damage to the CNS, or a multifactorial combination. Recent studies have highlighted the significance of neuroimaging techniques in diagnosing HUS encephalopathy. Efforts have been made to identify early neural biomarkers and develop corresponding treatments. Although various biomarkers have been reported, additional studies are needed for further development and standardization. Late-stage pharmacological treatments for encephalopathy are also discussed, both in clinical settings and experimental research.Keywords
Funding Information
- Agencia Nacional de Promoción Científica y Tecnológica (PICT-2021-00656)
- Secretaría de Ciencia y Técnica, Universidad de Buenos Aires (20020190100186BA)
- Consejo Nacional de Investigaciones Científicas y Técnicas (PIP11220200101293CO)
This publication has 205 references indexed in Scilit:
- Effects of Muse Cell on a Mouse Model With Acute EncephalopathyBrain and Behavior, 2025
- Shiga Toxin and Its Effect on the Central Nervous System2023
- Purtscher-Like Retinopathy in Hemolytic Uremic SyndromeJAMA Ophthalmology, 2019
- Clinical Trials of Muse Cells2018
- Thalamic involvement in patients with neurologic impairment due to Shiga toxin 2Annals of Neurology, 2012
- Epidemiology of inflammatory bowel disease in a German twin cohort: Results of a nationwide studyInflammatory Bowel Diseases, 2008
- Long-term Renal Prognosis of Diarrhea-Associated Hemolytic Uremic SyndromeJAMA, 2003
- P1 blood group antigen expression and epidemic hemolytic uremic syndromePediatric Nephrology, 1995
- Neurological involvement in hemolytic‐uremic syndromeAnnals of Neurology, 1986
- CNS Manifestations of the Hemolytic-Uremic SyndromeAmerican Journal of Diseases of Children, 1980